Adrenal Crisis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032


 Adrenal crisis (Addisonian crisis/acute adrenal insufficiency/bronze Addison disease) as a profound impairment of general health and at least two of the following conditions hypotension (systolic blood pressure 100mmHg), severe fatigue, vomiting or nausea, hyperkalemia, hypoglycemia, and hyponatremia triggering parenteral glucocorticoid administration. The risk factor associated with the adrenal crisis is diabetes insipidus, diabetes mellitus (type 1 and type 2), hypogonadism, adrenal hemorrhage, pregnancy, and polyglandular autoimmune syndrome 1 and 2. An adrenal crisis occurs when there is adrenal insufficiency, either primary or secondary. Primary adrenal crisis is characterized by high ACTH from the destruction of the adrenal gland and low cortisol. Secondary adrenal insufficiency is characterized by low cortisol and normal ACTH caused by decreased ACTH secretion from the pituitary. The tertiary cause includes the disruption of the hypothalamus, which affects the release of CRH and ACTH. In adrenal insufficiency, patients experience an acute stress event. They cannot adjust their usual dose of glucocorticoid therapy, causing their body cortisol stores to rapidly deplete, leading to an adrenal crisis as patients cannot produce cortisol.

·       In the United States, the prevalence of primary adrenal insufficiency is 40-100 cases per million, with an incidence of 6 cases per million.

Thelansis’s “Adrenal Crisis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Adrenal Crisis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Adrenal Crisis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Adrenal Crisis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Adrenal Crisis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Comments

Popular posts from this blog

Retinitis Pigmentosa (RP) – Market Access and Reimbursement Insights Report – 2025

Motor Neurone Disease (MND) – Market Access and Reimbursement Insights Report – 2025

Uncomplicated Gonorrhea – Market Outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2024 To 2034